Previous Next

Experimental Data

Posted on 14 Jul 2022 @ 8:55pm by Lieutenant JG Jane Sinclair MD, DVM

1,206 words; about a 6 minute read

Mission: General Sim Postings
Location: Medical Lab 1
Timeline: After SAR mission, before return to SB51

[ON]

Dr. Jane Sinclair had been looking into the pheromone issue that had plagued Lamia Arderne since she and a number of other crewmembers had been taken by Orions a few months earlier. Dr. Cahill had devised a treatment, which worked if administered monthly at a certain point in the patient's menstrual cycle, but the pheromones themselves hadn't been studied too closely.

And most peculiar, Jane had made an observation that she wanted to look further into. She wanted to do some tests, answer some questions, and ideally find a more permanent solution to the patient's problem.

**

Begin recording. Case file number 2394-001134. Patient is 37-year-old Betazoid/Drax hybrid female, aged 36 at time of incident, description in Annex A.

Patient subjected to a treatment which causes her body to emit pheromones, which peak along predictable hormonal cycles. Analysis of pheromone chemical composition reveals that it is similar to those put out by standard-phenotype Orion females, with certain structural modifications.

The effects of normal Orion pheromones on humanoid males includes an increase in metabolism and adrenaline production, which also increases libido and suggestibility. In humanoid females, they have been observed to cause headaches and feelings of jealousy. Vulcans have been shown to be immune.

The modified pheromone emitted by Patient has shown no evidence of causing harmful reactions in humanoid females of any species. It still increases male libido and sexual aggression, but since release from captivity, Patient has viewed this mostly positively.

Observation triggering this analysis:
Experimental Subject 1, human female, age 34, homosexual, observed to have some base reaction to exposure to the pheromone. Subject did not show sudden or noticeable increase in adrenaline or metabolism, but self-reported an increase in sex drive that was not attributable to another phenomenon.

Transparency and conflict of interest declaration: I am Experimental Subject 1.

Initial studies of standard-type Orion pheromones by the Chief Medical Officer of Earth Starfleet vessel Enterprise NX-01 in 2154 did not take sexual orientation of subjects into account. Subsequent studies observed some human experimental subjects who did not react to the Orion pheromone, but no causal link to sexual orientation was ever made.

My hypothesis is that the structural changes made to the pheromone negate the negative effects they have on women, and may cause a reaction in females that are attracted to females that is similar to the reaction in males that are attracted to females. This makes sense; if you're running a slave breeding program, as we understand these Orions were, you don't want to be hindered by competition among the women, and any unforeseen sexual attraction among women slaves would not be a hindrance.

Experimental setup:
Note: sample size is intentionally very small for this initial test, as it is meant to determine whether there is any cause for further study. In case of nil reaction, no further work will be undertaken. No sense in wasting resources in a large-scale double-blind study if the initial observation was a fluke. I will write a proposal for a larger, more controlled experiment if we see any interesting reactions.

Four subjects have been identified and brought to Medical Lab 1, which has been put into full isolation mode for the test. All four are cis-gender humans. Sensors are set up to constantly scan the following parameters in all four individuals: pheromone intake through inhalation and skin absorption, noradrenaline and adrenaline levels, metabolic rate, heart rate, activity in the hypothalamus, amygdala, and nucleus accumbens, and blood flow to the sexual organs.

Experimental Subject 1 is also the test administrator. 34-year-old homosexual human female.

Experimental Subject 2 is a heterosexual human female, age 32.

Experimental Subject 3 is a homosexual human male, age 29.

Experimental Subject 4 is a heterosexual human male, age 32.

The pharmaceutical replicator has produced a sizeable quantity of pheromone identical to that produced by the Patient. This has been formulated into a liquid spray at four times the concentration produced by the Patient. This spray will be administered to the neck of a Subject. Each other Subject will be asked to hold the exposed Subject close and inhale deeply. Subjects will describe any sensations, while the lab sensors collect all necessary data.

The Subject receiving the spray will be given a nose plug to prevent cross-contamination effects. The spray will be washed off using a neutralizing agent known to work on pheromones after all three other Subjects are finished.

All four Subjects are wearing clean clinical scrubs, which do not cover the neck, and no undergarments. None of the subjects have reported finding any of the other ones unattractive, negating a potential revulsion factor.

A hypospray containing Ambizine is ready in case overly aggressive Subjects must be stopped. The experiment will cease if that happens.

Study begins now.


**

"All right," Jane began, addressing the other three in the room. "You know what to do. I spray you in the neck and I step back. One at a time, the others give you a big hug and hold for two minutes, breathing deeply. I'll be asking questions, except when it's my turn, where I'll just be talking out loud. Try to be mindful of your feelings and what your body is telling you. Try not to let things get out of hand. Any questions?"

"Who is going first?" This was Lucy Duvalle, the group's straight woman.

"I will," Jane answered. "My hypothesis is that I'll receive a reaction from Mr. Craig here, but nothing from you. The trick is whether anything will happen to Mr. Lancaster. The order of those smelling will always be the person for whom I expect a reaction, the one for whom I expect none, and the mystery."

The doctor picked up the spray bottle and held it aloft. "Shall we begin?"

**

Resume recording. That could not have gone better.

I'll need to study the brain scans closely but my present hypothesis is that male and female biologies are reacting identically to the pheromone, but that connections in the brain related to sexual orientation interfere with signal transmission when the person emitting the pheromone isn't someone we want to mate with.

So it seems the pheromone emitted by the Patient isn't attracting men, it's attracting people who want to have sex with women.

One thing is certain, the typical negative effects Orion pheromones have on human women is disabled in this variant.

I'll be reviewing the scans over the next few days. If it looks like I'm right, then I'll propose a larger experiment. Perhaps with holographic people who can emit the pheromone, so we can control for other factors. I'm not sure how we'll make it a double-blind test, but I'm sure we'll think of something.

Ugh. I might have a mistake in having Subject 2 be the last to receive the spray. I can report that it definitely worked on me. Subject 2 isn't exactly my type but I...goodness, I started kissing my way down her chest, didn't I? Thankfully the clock stopped me. I'm still feeling it, even with the pheromone and the person gone. Maybe I overdid it.

*pause*

Computer, locate First Lieutenant Macapuno.

=/\= First Lieutenant Macapuno is in her quarters =/\=

Fantastic.

Oh, bollock. Computer, end recording, and delete the last thirty seconds.


[OFF]

Lieutenant junior grade Jane Sinclair
Deputy Chief Medical Officer

 

Previous Next

RSS Feed RSS Feed